Translate this page into:
An unusual cause of breath-holding spell in a leukemic infant: Cytarabine
*Corresponding author: Zühre Kaya, Department of Pediatric Hematology, Gazi University School of Medicine, Ankara, Turkey. zuhrekaya@gazi.edu.tr
-
Received: ,
Accepted: ,
How to cite this article: Kirkiz Kayalı S, Topuz Türkcan B, Kaya Z. An unusual cause of breath-holding spell in a leukemic infant: Cytarabine. J Hematol Allied Sci. 2024;4:54-5. doi: 10.25259/JHAS_52_2023
A previously healthy 14-month-old female infant was diagnosed with leukemia. She was in complete remission following induction chemotherapy of the Interfant-06 protocol. Her complete blood count was within normal limits. After the first four cytarabine infusions, she developed a fever, palmar erythema, and edema [Figure 1]. Chemotherapy was discontinued. Cellulitis was suspected, and thus, broad-spectrum antibiotics were started. Her complaint was alleviated. When cytarabine infusion was restarted, fever, bilateral palmar erythema, edema, breath-holding spells, and cyanosis were observed [Video 1]. Her electroencephalogram revealed no abnormalities. All of these findings have been attributed to secondary cytarabine. Both immediate and delayed hypersensitivity reactions to cytarabine have been reported.[1,2] For allergic reactions, 1 mg/kg methylprednisolone plus antihistamine was administered before cytarabine infusion. All symptoms disappeared. She completed the chemotherapy protocol.
Based on a literature search, the breath-holding spell in a leukemic child caused by cytarabine has been documented for the 1st time.
Ethical approval
The Institutional Review Board approval is not required.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript, and no images were manipulated using AI.
Videos available on:
Financial support and sponsorship
Nil.
References
- Successful administration of cytarabine after a previous anaphylactic reaction. Allergy. 1997;52:1009-11.
- [CrossRef] [PubMed] [Google Scholar]
- Hypersensitivity reaction to high-dose cytarabine. Br J Haematol. 1989;73:274-5.
- [CrossRef] [PubMed] [Google Scholar]